メタルフェノール膜を持つペプチドコアセルバートは,グルコース代謝を調節し,がん免疫療法を強化する

Xin Zheng^1,2, Shiqiong Lei³, Yiwei Zeng^4,5

¹Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Advanced materials (Deerfield Beach, Fla.)

|September 3, 2025

まとめ

ナノ粒子は腫瘍のグルコースを T細胞に誘導し抗がん免疫を高めますこの代謝再プログラムにより T細胞の活性化が強化され免疫療法への抵抗が克服され新しいがん治療戦略が提供されます

科学分野:

生物医学工学
ガン免疫学
代謝療法

背景:

腫瘍のグルコース消費はT細胞の機能を制限し,免疫回避と癌の進行を促進します.
細胞代謝を標的とするのが有望ながん免疫療法戦略ですが,T細胞にグルコースを転送することは困難です.
インターフェロンアルファ (IFNα) は免疫応答の調節に作用する.

研究の目的:

IFNα (PC-IFNα@MPNs) を供給する金属フェノールネットワークを持つ合成ペプチドコアセルバート (PC) を開発し,T細胞の抗腫瘍活性を強化する.
T細胞と腫瘍細胞の代謝を調節するPC-IFNα@MPNのメカニズムを調査する.
臨床前がんモデルにおける免疫チェックポイントブロック (ICB) と組み合わせたPC-IFNα@MPNの治療効果を評価する.

主な方法:

持続的なIFNα放出とT細胞共刺激のためのPC-IFNα@MPNの製造
T細胞と腫瘍細胞におけるグルコースの吸収と糖分解の評価
腫瘍の成長抑制,T細胞の浸透,および活性化を評価するために,オーソトーピック腫瘍マウスモデルを用いたインビオ研究.
ICBによる併用療法と免疫記憶効果の評価

主要な成果:

PC-IFNα@MPNsは,LFA-1構造を調節することによって,T細胞のグルコース吸収とグリコロシスを促進した.
PC-IFNα@MPNsからの持続的なIFNα放出は,腫瘍細胞の糖分解を抑制し,T細胞のエネルギー供給を増加させた.
PC- IFNα@MPNは腫瘍の成長を抑制し,T細胞の浸透と活性化を強化し,ICBで有意な有効性を示した (99%の腫瘍の成長抑制).
治療は強い免疫記憶を誘発し 74日以上腫瘍の再発を防ぎました

結論:

PC-IFNα@MPNは,グルコース利用を調節することによって,がんにおける代謝介入のための新しい戦略を表しています.
このアプローチはT細胞の機能を強化し,ICBに対する抵抗を克服し,強力な治療プラットフォームを提供します.
金属有機材料は長期的な効果を持つ先進的ながん免疫療法を開発するための合理的な設計を提供します

キーワード:

メタルフェノールネットワーク T細胞の活性化ガン治療の組み合わせメモリT細胞メタボリックモジュレーション

さらに関連する動画

08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.3K

10:23

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Published on: May 3, 2024

1.0K

関連する概念動画

01:27

Tumor Immunotherapy

659

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

659

01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.9K

02:50

Combination Therapies and Personalized Medicine

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

5.1K

02:38

Mitogens and the Cell Cycle

6.6K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

6.6K

01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.8K

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: